je.st
news
Tag: drug
Reichert Offers Advanced Tools For Pre-Clinical Drug Development
2013-10-02 06:13:22| drugdiscoveryonline News Articles
The development of drugs and the deciphering of biological processes will be made easier when data from Reichert Surface Plasmon Resonance (SPR) systems manufactured in the United States are evaluated with Swedish software
Tags: advanced
tools
development
offers
NEOMED Selects Its First Drug Development Project And Targets The Influenza Virus
2013-10-02 06:07:26| drugdiscoveryonline News Articles
NEOMED, a not-for-profit organization whose mission is to create a bridge between academic research and the pharmaceutical industry, is proud to announce the launch of its first drug development project
Tags: the
development
project
drug
ProStrakan Launching SANCUSO (Granisetron Transdermal System) In European Union With 3M Drug Delivery Systems As Manufacturer
2013-10-02 06:03:06| drugdiscoveryonline News Articles
The European Medicines Agency (EMA) has granted approval for ProStrakan Group plc to market SANCUSO (Granisetron Transdermal System) in the European Union (EU), with 3M Drug Delivery Systems acting as the manufacturer.
Tags: system
systems
delivery
union
'CureDuchenne Ventures' Launched To Accelerate Drug Discovery And Development For Duchenne Muscular Dystrophy
2013-10-02 05:57:32| drugdiscoveryonline News Articles
CureDuchenne announced today the launch of CureDuchenne Ventures, a new initiative to identify and develop a robust pipeline of therapies to treat Duchenne, the most common and lethal form of muscular dystrophy
Tags: development
drug
discovery
launched
Vertex Submits Supplemental New Drug Application (sNDA) To U.S. Food And Drug Administration For KALYDECO (ivacaftor) Monotherapy For People With Non-G551D Gating Mutations
2013-10-02 05:50:27| drugdiscoveryonline News Articles
Vertex Pharmaceuticals Incorporated recently announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the approval of KALYDECOTM (ivacaftor) monotherapy for people with cystic fibrosis (CF) ages 6 and older who have at least one non-G551D gating mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
Tags: with
people
food
application
Sites : [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] next »